Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
12.75    -0.25 (-1.92%)
Bid:
12.00
Ask:
13.50
Spread: 1.50 (12.50%)
Market Cap: £15.94m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Acquisition

18 Jun 2007 07:01

Fabian Romania Property Fund Ltd18 June 2007 18 June 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or "Fabian") Fabian Romania acquires the Baneasa Business Center in north Bucharest fromImmoconsult for €23.9 million Fabian Romania is pleased to announce that it has entered into an agreement topurchase its seventh office project in central north Bucharest from ImmoconsultLeasinggesellschaft m.b.H, with a transaction value of €23.9 million. Oncerefinanced, Fabian Romania's net equity investment will be €5 million. Theannual rental income is approximately €1.85 million per annum. Since itsAdmission to AIM, Fabian Romania has entered into four investments committingapproximately €34 million of the funds raised. The Baneasa Business Center provides 9,600 square metres of lettable space andis fully let. It is located in the central business district of north Bucharestand has a highly visible and prominent 32 metre frontage to Bucaresti-PloiestiSt, which runs directly north to the International airport. The immediatevicinity is well serviced by the main transport systems of Bucharest, and iswithin one of the fastest growing development locations of the city for bothoffice and retail estates. The Bucaresti-Ploiesti highway leads directly fromthe city center to Ploiesti City and links to the main E60 road to Brasov andTransylvania. The building offers good flexibility, having been constructed in three phases ina "Z" shape. Phase 1 of the building comprises a ground floor plus seven levels,whilst phases 2 and 3 both provide ground floor and nine upper levels, all werebuilt to Class A specification. Overground and underground parking facilitiesprovide for 132 vehicles. The Baneasa Business Center is currently fully let to fourteen internationaltenants, including Wrigley, Colgate, Fresenius, Cargill and Volksbank. There area variety of reversionary leases at rents between €12 per square metre to €16per square metre, providing an annual rental income of approximately €1.85million per annum. Concurrent with signing the acquisition Fabian has concluded debt financing withthe vendor's parent company Investkredit, via an 80 per cent. facility, reducingthe net equity requirement of Fabian Romania to approximately €5 million. Thisis the fourth credit facility Fabian has agreed with Investkredit in Romania. Claudius Ferentz, Managing Director of Investkredit Romania, quoted "This isanother exciting acquisition for Fabian and we are very pleased to have againpartnered them in providing an excellent financial services in a competitiveenvironment". Investkredit used the same team as per previous Fabian transactions, whichincluded Salans advising on legal aspects and NNKP representing Fabian. Responsible for the acquisition, Mark Owen, Property Director of Fabian Capital,Fabian Romania's investment adviser said: "This is further exciting news from Fabian, with three transactions announcedover the last three weeks. This acquisition adds an exciting asset managementopportunity to the Fabian Romania portfolio and has been converted from thepipeline discussed with investors at AIM admission. Over the medium term weshall aim to renegotiate the tenants' leases as they come up for renewal tocreate added value. The building is extremely flexible in design and is able toprovide floor plates between 700-1000sqm for which there is a shortage in themarket. Our ability to purchase a building of this type clearly sets us apartfrom our competitors and enables us to diversify in a fast moving emergingmarket". The lead advisers on the transaction were Eurisko (property agent), WSP(technical adviser), NNKP (legal adviser), KPMG (financial and tax adviser) andBiris Goran (legal advisor to Immoconsult) For Comments: Fabian Romania:Mark Holdsworth +44 20 7499 9988 Nominated Adviser:Deloitte & Touche LLPJames Lewis +44 20 7936 3000 Broker:Shore Capital Stockbrokers LimitedDru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Nov 20207:00 amRNSNotice of Results
28th Oct 20204:41 pmRNSSecond Price Monitoring Extn
28th Oct 20204:36 pmRNSPrice Monitoring Extension
27th Oct 20207:00 amRNSReceipt of grants from Invest Northern Ireland
25th Sep 202011:38 amRNSResult of AGM
24th Sep 20202:39 pmRNSDirector/PDMR Shareholding
22nd Sep 20205:16 pmRNSHolding(s) in Company
18th Sep 20209:31 amRNSUpdate on R&D programme
28th Aug 20207:00 amRNSNotice of AGM
19th Aug 20207:00 amRNSFinal Results
11th Aug 20209:33 amRNSQueens University Belfast funding
31st Jul 20205:00 pmRNSTotal Voting Rights
7th Jul 20202:12 pmRNSExercise of Options
6th Jul 20204:41 pmRNSSecond Price Monitoring Extn
6th Jul 20204:36 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSTrading update
4th Jun 202012:57 pmRNSHolding(s) in Company
29th May 20205:00 pmRNSTotal Voting Rights
21st May 20206:24 pmRNSHolding(s) in Company
21st May 20202:52 pmRNSHolding(s) in Company
15th May 20204:49 pmRNSHolding(s) in Company
15th May 202010:47 amRNSResult of General Meeting & Total Voting Rights
15th May 20208:30 amRNSHolding(s) in Company
28th Apr 20207:00 amRNSPlacing to raise £3m, trading update, notice of GM
17th Apr 20204:41 pmRNSSecond Price Monitoring Extn
17th Apr 20204:35 pmRNSPrice Monitoring Extension
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:36 pmRNSPrice Monitoring Extension
16th Apr 20203:51 pmRNSResearch Alliance with Queen’s University Belfast
16th Apr 20202:06 pmRNSSecond Price Monitoring Extn
16th Apr 20202:01 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSTrading update
19th Mar 20207:00 amRNSBelfast investor presentation
17th Mar 20207:00 amRNSDirector/PDMR Shareholding
17th Feb 20207:00 amRNSBelfast investor presentation
3rd Feb 202012:01 pmRNSDirector/PDMR Shareholding
30th Jan 20204:40 pmRNSSecond Price Monitoring Extn
30th Jan 20204:35 pmRNSPrice Monitoring Extension
29th Jan 20207:00 amRNSTrading update
10th Jan 202011:47 amRNSDirector/PDMR Shareholding
3rd Dec 20199:26 amRNSDirector/PDMR Shareholding
2nd Dec 20197:00 amRNSHalf-year Report
26th Nov 201911:13 amRNSNotice of Results
22nd Oct 20197:00 amRNSHalf year trading update
26th Sep 20199:54 amRNSDirector/PDMR Shareholding
20th Sep 20192:14 pmRNSResult of AGM
21st Aug 20197:00 amRNSPosting of Annual Report & Notice of AGM
3rd Jul 20194:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20197:00 amRNSFinal Results
29th Apr 20192:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.